|
Title
|
|
|
|
Subtractive immunization as a method to develop respiratory syncytial virus (RSV)—specific monoclonal antibodies
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Respiratory Syncytial Virus (RSV) is a significant cause of lower respiratory tract infections in the young, the elderly, and in immunodeficient patients. As such, the virus represents an important cause of morbidity and mortality worldwide. Development of monoclonal antibodies against RSV has resulted in a commercial prophylaxis, palivizumab (Synagis®), and different antibodies that have improved our understanding of the structure of the viral proteins. In this study, a different immunization technique, subtractive immunization, was evaluated for its applicability to develop RSV-specific antibodies. One hybridoma which produced antibodies with the strongest staining of RSV infected cells, ATAC-0025, was selected for further characterization. This antibody belongs to the IgG1 class, has neutralizing capacity and recognizes the envelope F-protein. The antibody has a broad reactivity against a range of RSV reference strains and clinical isolates. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Antibodies
| |
|
Publication
|
|
|
|
2023
| |
|
ISSN
|
|
|
|
2073-4468
| |
|
DOI
|
|
|
|
10.3390/ANTIB12040062
| |
|
Volume/pages
|
|
|
|
12
:4
(2023)
, p. 1-12
| |
|
Article Reference
|
|
|
|
62
| |
|
ISI
|
|
|
|
001130825500001
| |
|
Pubmed ID
|
|
|
|
37873859
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|